SFM
UTHR icon

Signet Financial Management’s United Therapeutics UTHR Stock Holding History

Signet Financial Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Sell
10,781
-159
-1% -$79.2K 0.72% 41
2025
Q4 		$5.33M Sell
10,940
-36
-0.3% -$16.8K 0.6% 51
2025
Q3 		$4.6M Buy
10,976
+59
+0.5% +$19.8K 0.53% 58
2025
Q2 		$3.14M Buy
10,917
+22
+0.2% +$6.58K 0.39% 82
2025
Q1 		$3.36M Buy
10,895
+79
+0.7% +$27.1K 0.45% 74
2024
Q4 		$3.82M Buy
10,816
+103
+1% +$37.9K 0.49% 65
2024
Q3 		$3.84M Buy
10,713
+413
+4% +$140K 0.49% 64
2024
Q2 		$3.28M Buy
+10,300
New +$2.73M 0.44% 74
2018
Q4 		– Sell
-35,877
Closed -$4.59M – 799
2018
Q3 		$4.59M Sell
35,877
-1,296
-3% -$160K 0.8% 41
2018
Q2 		$4.21M Sell
37,173
-1,043
-3% -$115K 0.74% 53
2018
Q1 		$4.29M Buy
+38,216
New +$4.85M 0.77% 52

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Signet Financial Management's UTHR Position: Q1 2026 in Review

Signet Financial Management reduced its United Therapeutics (UTHR) stake by 1.5% in Q1 2026, selling an estimated $79.2K and leaving 10,781 shares worth $6.39M. The position accounts for 0.72% of the portfolio, ranked #41.

Signet Financial Management first reported a position in UTHR in Q1 2018 and has held it in 11 quarters since. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Signet Financial Management held 10,781 shares of United Therapeutics worth $6.39M as of Q1 2026.
  • Signet Financial Management sold 159 United Therapeutics shares in Q1 2026, an estimated $79.2K.
  • United Therapeutics made up 0.72% of Signet Financial Management's portfolio in Q1 2026, its #41 holding.
  • Signet Financial Management first reported a position in United Therapeutics in Q1 2018 and has held it in 11 quarters since.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.